Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sernova Corp SEOVF


Primary Symbol: T.SVA

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

Recent & Breaking News (TSX:SVA)

Sernova is Awarded Patents in Multiple Countries for Cell Pouch(TM) and Therapeutic Cell Transplantation Technologies

Marketwired February 12, 2015

Sernova to Participate in Biotech Showcase(TM) 2015 Healthcare Conference in San Francisco

Marketwired January 12, 2015

Sernova Provides Corporate Update

Marketwired November 10, 2014

Sernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of Diabetes

Marketwired July 15, 2014

Sernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San Diego

Marketwired June 24, 2014

Sernova's CEO Dr. Philip Toleikis Featured on BNN

Marketwired June 20, 2014

Sernova Provides Corporate Update and Results of 2014 Annual General Meeting

Marketwired June 3, 2014

Sernova Receives Patent Allowance for Cell Pouch(TM) and Therapeutic Cell Transplantation Technologies

Marketwired May 14, 2014

Kevin Egan Joins Sernova as Chair Business Advisory Board

Marketwired May 12, 2014

Sernova Announces Appointment of Nick Borrelly to Corporate Development Role

Marketwired May 7, 2014

Sernova's Cell Pouch(TM) Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility

Marketwired April 22, 2014

Sernova's Cell Pouch(TM) Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility

Marketwired April 22, 2014

Sernova Announces Annual Meeting, Record Date and Adopts Advance Notice By-Law

Marketwired February 26, 2014

Frank Holler Joins Sernova's Board of Directors

Marketwired February 11, 2014

Sernova Announces Appointment of Cathy Steiner as CFO

Marketwired January 31, 2014

Sernova to Present Company and Clinical Update at Biotech Showcase(TM) Healthcare Conference in San Francisco

Marketwired January 13, 2014

Sernova Corp Engages Carson Seabolt and Network IR

Marketwired November 27, 2013

World First: Sernova's Cell Pouch(TM) Shown to Provide a Safe Environment for Therapeutic Insulin Producing Islets in Humans with Type 1 Diabetes

Marketwired September 26, 2013

Sernova Corp Engages Ray Matthews & Associates

Marketwired September 11, 2013

Sernova and Medicyte to Collaborate on Cell-Based Therapy to Treat Haemophilia

Marketwired September 10, 2013